MiR-373-3p promotes invasion and metastasis of lung adenocarcinoma cells

Chinese Journal of Lung Cancer

Volumn 18, Issue 7, 2015, Pages 427-435

  Wu, Aibing ^a   Li, Jinmei ^a   Wu, Kunpeng ^a   Mo, Yanli ^a   Luo, Yiping ^a   Ye, Haiyin ^a   Shen, Xiang ^a   Li, Shujun ^a   Liang, Yahai ^a   Liu, Meilian ^a   Yang, Zhixiong ^a  

^a GUANGDONG MEDICAL UNIVERSITY   (China)

Author keywords

Invasion; Lung neoplasms; Metastasis; MiR 373; MMP 14; MMP 9

Indexed keywords

GELATINASE B; MATRIX METALLOPROTEINASE 14; MICRORNA; MICRORNA 373 3P; UNCLASSIFIED DRUG; MIRN373 MICRORNA, HUMAN;

ARTICLE; CELL INVASION ASSAY; DOWN REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG ADENOCARCINOMA; METASTASIS; NON SMALL CELL LUNG CANCER; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR INVASION; UPREGULATION; WESTERN BLOTTING; ADENOCARCINOMA; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ADENOCARCINOMA; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 9; MICRORNAS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS;

EID: 84937549220     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: 10.3779/j.issn.1009-3419.2015.07.07     Document Type: Article

References (23)

1. 1 Siegel R, Ma J, Zou Z, et al. Cancer statistics, 2014. CA Cancer J Clin, 2014, 64(1): 9-29.
2. 2 Jemal A, Bray F, Center M M, et al. Global cancer statistics. CA Cancer J Clin, 2011, 61(2): 69-90.
3. 3 Bartel D P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 2004, 116(2): 281-297.
4. 4 Nicoloso MS, Spizzo R, Shimizu M, et al. MicroRNAs-the micro steering wheel of tumour metastases. Nat Rev Cancer, 2009, 9(4): 293-302.
5. 5 Kwak MS, Lee DH, Cho Y, et al. Association of polymorphism in primicroRNAs- 371-372-373 with the occurrence of hepatocellular carcinoma in hepatitis B virus infected patients. PLoS One, 2012, 7(7): e41983.
6. 6 Huang Q, Gumireddy K, Schrier M, et al. The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nat Cell Biol, 2008, 10(2): 202-210.
7. 7 Liu P, Wilson MJ. miR-520c and miR-373 upregulate MMP9 expression by targeting mTOR and SIRT1, and activate the Ras/Raf/MEK/Erk signaling pathway and NF-κB factor in human fibrosarcoma cells. J Cell Physiol, 2012, 227(2): 867-876.
8. 8 Zhang X, Li X, Tan Z, et al. MicroRNA 373 is upregulated and targets TNFAIP1 in human gastric cancer, contributing to tumorigenesis. Oncol Lett, 2013, 6(5): 1427-1434.
9. 9 Seol H S, Akiyama Y, Shimada S, et al. Epigenetic silencing of microRNA-373 to epithelial-mesenchyma transition in non-small cell lung cancer through IRAK2 and LAMP1 axes. Cancer Lett, 2014, 353(2): 232-241.
10. 10 Wang LQ, Zhang Y, Yan H, et al. MicroRNA-373 functions as an oncogene and targets YOD1 gene in cervical cancer. Biochem Biophys Res Commun, 2015, 459(3): 515-520.
11. 11 Nakata K, Ohuchida K, Mizumoto K, et al. Micro RNA-373 is downregulated in pancreatic cancer and inhibits cancer cell invasion. Ann Surg Oncol, 2014, 21(4): 564-574.
12. 12 Zhang Y, Zhao FJ, Chen LL, et al. MiR-373 targeting of the Rab22a oncogene suppresses tumor invasion and metastasis in ovarian cancer. Oncotarget, 2014, 5(23): 12291-12303.
13. 13 Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell, 2010, 141(1): 52-67.
14. 14 Radisky ES, Radisky DC. Matrix metalloproteinase-induced epithelialmesenchymal transition in breast cancer. J Mammary Gland Biol, 2010, 15(2): 201-212.
15. 15 Peng WJ, Zhang JQ, Wang BX, et al. Prognostic value of matrix metalloproteinase 9 expression in patients with non-small cell lung cancer. Clin Chim Acta, 2012, 413(13): 1121-1126.
16. 16 Li HC, Cao DC, Liu Y, et al. Prognostic value of matrix metalloproteinases (MMP-2 and MMP-9) in patients with lymph node-negative breast carcinomar. Breast Cancer Res Treat, 2004, 88(1): 75-85.
17. 17 Vizoso FJ, Gonzalez LO, Corte MD, et al. Study of matrix metalloproteinases and their inhibitors in breast cancer. Br J Cancer, 2007, 96(6): 903-911.
18. 18 Hao L, Zhang C, Qiu Y, et al. Recombination of CXCR4, VEGF, and MMP-9 predicting lymph node metastasis in human breast cancer. Cancer Lett, 2007, 253(1): 34-42.
19. 19 Jiang W G, Davies G, Martin T A, et al. Expression of membrane type-1 matrix metalloproteinase, MT1-MMP in human breast cancer and its impact on invasiveness of breast cancer cells. Int J Mol Med, 2006, 17(4): 583-590.
20. 20 Takino T, Tsuge H, Ozawa T, et al. MT1-MMP promotes cell growth and ERK activation through c-Src and paxillin in three-dimensional collagen matrix. Biochem Biophys Res Commun, 2010, 396(4): 1042-1047.
21. 21 Tolde O, Rosel D, Mierke CT, et al. Neoplastic progression of the human breast cancer cell line G3S1 is associated with elevation of cytoskeletal dynamics and upregulation of MT1-MMP. Int J Oncol, 2010, 36(4): 833-839.
22. 22 Demidyuk IV, Shubin AV, Gasanov EV, et al. Alterations in gene expression of proprotein convertases in human lung cancer have a limited number of scenarios. PLoS One, 2013, 8(2): e55752.
23. 23 Wang Y, Wu K, Wu A, et al. MMP-14 overexpression correlates with poor prognosis in non-small cell lung cancer. Tumor Biol, 2014, 35(10): 9815-9821.